KHK4951

DRUG3 trials

Sponsors

Kyowa Kirin Co., Ltd.

Conditions

Diabetic Macular Edema (DME)Healthy VolunteersNeovascular Age-Related Macular Degeneration (nAMD)Wet Age-related Macular Degeneration

Phase 1

A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

TerminatedNCT04594681

Kyowa Kirin Co., Ltd.Healthy Volunteers, Wet Age-related Macular Degeneration

Start: 2020-09-16End: 2022-08-26Updated: 2023-05-18

Phase 2

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Active, not recruitingNCT06116890

Kyowa Kirin Co., Ltd.Neovascular Age-Related Macular Degeneration (nAMD)

Start: 2024-01-31End: 2026-09-30Target: 180Updated: 2025-10-30

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Active, not recruitingNCT06116916

Kyowa Kirin Co., Ltd.Diabetic Macular Edema (DME)

Start: 2024-01-09End: 2026-09-30Target: 150Updated: 2025-10-30